These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24122335)

  • 1. Pathology in drug discovery and development.
    Jubb AM; Koeppen H; Reis-Filho JS
    J Pathol; 2014 Jan; 232(2):99-102. PubMed ID: 24122335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers: refining diagnosis and expediting drug development - reality, aspiration and the role of open innovation.
    Salter H; Holland R
    J Intern Med; 2014 Sep; 276(3):215-28. PubMed ID: 24605903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. US FDA perspective on challenges in co-developing in vitro companion diagnostics and targeted cancer therapeutics.
    Philip R; Carrington L; Chan M
    Bioanalysis; 2011 Feb; 3(4):383-9. PubMed ID: 21338257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New science-based endpoints to accelerate oncology drug development.
    Kelloff GJ; Sigman CC
    Eur J Cancer; 2005 Mar; 41(4):491-501. PubMed ID: 15737552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biomarker is not the end.
    Nohaile M
    Drug Discov Today; 2011 Oct; 16(19-20):878-83. PubMed ID: 21888986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges of biomarkers in drug discovery and development.
    Goodsaid F
    Expert Opin Drug Discov; 2012 Jun; 7(6):457-61. PubMed ID: 22471322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse tumour models to guide drug development and identify resistance mechanisms.
    Das Thakur M; Pryer NK; Singh M
    J Pathol; 2014 Jan; 232(2):103-11. PubMed ID: 24122209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
    Dietel M; Jöhrens K; Laffert M; Hummel M; Bläker H; Müller BM; Lehmann A; Denkert C; Heppner FL; Koch A; Sers C; Anagnostopoulos I
    Cancer Gene Ther; 2013 Apr; 20(4):211-21. PubMed ID: 23492822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biomarkers: "Found in translation"].
    Lockhart BP; Walther B
    Med Sci (Paris); 2009 Apr; 25(4):423-30. PubMed ID: 19409197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The zebrafish: a powerful platform for in vivo, HTS drug discovery.
    Delvecchio C; Tiefenbach J; Krause HM
    Assay Drug Dev Technol; 2011 Aug; 9(4):354-61. PubMed ID: 21309713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of imaging biomarkers in the early clinical development of central nervous system therapeutic agents.
    Cole PE; Schwarz AJ; Schmidt ME
    Clin Pharmacol Ther; 2012 Feb; 91(2):315-20. PubMed ID: 22218072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational paradigms in pharmacology and drug discovery.
    Mullane K; Winquist RJ; Williams M
    Biochem Pharmacol; 2014 Jan; 87(1):189-210. PubMed ID: 24184503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Horizon scanning for novel therapeutics for the treatment of prostate cancer.
    Bianchini D; Zivi A; Sandhu S; de Bono JS
    Expert Opin Investig Drugs; 2010 Dec; 19(12):1487-502. PubMed ID: 20868208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerating safe drug development: an ideal approach to approval.
    Grever MR
    Hematology Am Soc Hematol Educ Program; 2013; 2013():24-9. PubMed ID: 24319158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative oncology drug discovery accompanied by preclinical translational research as prerequisite for clinical development.
    Hoffmann J
    Chin Clin Oncol; 2014 Jun; 3(2):15. PubMed ID: 25841411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of pharmacokinetic/pharmacodynamic biomarkers to support rational cancer drug development.
    Sarker D; Pacey S; Workman P
    Biomark Med; 2007 Oct; 1(3):399-417. PubMed ID: 20477383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers in clinical drug development.
    Gobburu JV
    Clin Pharmacol Ther; 2009 Jul; 86(1):26-7. PubMed ID: 19536121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.